Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
2023 Standout
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
2022 Standout
2 intermediate papers

Works of Michael Pearlman being referenced

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines
2003
Increased CD38 expression is associated with favorable prognosis in adult acute leukemia
2000

Author Peers

Author Last Decade Papers Cites
Michael Pearlman 35 16 31 28 9 110
Helen Casbolt 11 6 48 13 8 165
Nobuo Sezaki 11 3 23 18 13 103
Martyn Ronald Schaafsma 54 8 60 69 11 171
Christina Sternberg 32 3 143 18 6 184
Kathleen G. Halka 61 3 84 14 10 189
Krista M. Isaac 31 7 22 60 11 103
Kayleen Bailey 29 12 78 14 10 133
John C. Byrd 39 3 65 14 10 133
Evridiki Michalis 30 17 40 22 7 81
Calin Manta 25 2 37 6 10 179

All Works

Loading papers...

Rankless by CCL
2026